Viracta Therapeutics, Inc. (VIRX) Reports In-Line Q1 EPS

Viracta Therapeutics, Inc. (NASDAQ: VIRX) reported Q1 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Viracta Therapeutics, Inc. (VIRX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Morgan Stanley lifts server market TAM to $809B, boosts targets on compute stocks
• William Blair Upgrades Backblaze Inc (BLZE) to Market Perform